Vir Biotechnology (NASDAQ:VIR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Vir Biotechnology beat estimated earnings by 28.95%, reporting an EPS of $3.92 versus an estimate of $3.04.
Revenue was up $811.01 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.8 which was followed by a 14.78% drop in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
